课题基金 / 基金详情

Molecular determinants of progression and treatment response in melanoma

Molecular determinants of progression and treatment response in melanoma
黑色素瘤进展和治疗反应的分子决定因素
批准号:
nhmrc : 1045866
负责人:
Prof Richard Scolyer
金额:
$31.14万
依托单位国家:
澳大利亚
项目类别:
Practitioner Fellowships
财政年份:
2013
资助国家:
澳大利亚
项目状态:
已结题
起止时间:
2013-01-01 至 2017-12-31

项目摘要

项目成果

Prof Richard Scolyer的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Melanoma, a skin malignancy of pigment cells, is a major Australian health problem and is the commonest cancer in young adults. This project utilises the resources of the world’s largest melanoma treatment service and aims to develop a scientific basis for 1) improved management of individuals at high risk for melanoma progression, and 2) improved treatment of patients with early and disseminated melanoma, in an era of rapid change in the prospects of successfully treating this dangerous cancer.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Improving clinical outcomes of melanoma patients
  • 批准号:
    nhmrc : 1141295
  • 项目类别:
    Practitioner Fellowships
  • 资助金额:
    $39.03万
  • 财政年份:
    2018
  • 负责人:
    Prof Richard Scolyer
  • 依托单位:
Improving clinical outcomes of melanoma patients
  • 批准号:
    nhmrc : GNT1141295
  • 项目类别:
    Practitioner Fellowships
  • 资助金额:
    $57.72万
  • 财政年份:
    2018
  • 负责人:
    Prof Richard Scolyer
  • 依托单位:
海外基金